| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |